A multinational, pharmaceutical-grade medical cannabis and hemp extracts company, Clever Leaves, was recently granted a good agricultural and collecting practices (GACP) certification by the Control Union Medical Cannabis Standard (CUMCS) for meeting their guidelines for consistency and quality in the cultivation and harvest of medicinal cannabis.
A multinational, pharmaceutical-grade medical cannabis and hemp extracts company, Clever Leaves, was recently granted a good agricultural and collecting practices (GACP) certification by the Control Union Medical Cannabis Standard (CUMCS) for meeting their guidelines for consistency and quality in the cultivation and harvest of medicinal cannabis (1).
CUMCS’s standards offer general technical guidance for obtaining high-quality medicinal plant materials for the sustainable production of herbal items categorized as medicinal products. With the GACP certification, Clever Leaves is able to show that they operate under CUMCS procedures, cultivating crops that are free of heavy metals and agrochemicals as well as protocols for biodiversity safety in pharmaceutical manufacturing.
In Clever Leaves press release the company stated (1): “The CUMCS certification standard is based on GACP guidelines of The World Health Organization (WHO), the GACP Guidelines of the European Medicines Agency, Guidelines of the Dutch Government for Cannabis for Medical Use, and the International Standard for Good Agriculture Practice.”
“GACP certification reflects Clever Leaves’ ability to produce pharmaceutical-grade cannabis as well as our adherence to stringent operational standards,” said Kyle Detwiler, the CEO of Clever Leaves (1). “Achieving internationally-recognized quality guidelines will enable us to bring value at every touch point of the supply chain.”
With the GACP certification, Clever Leaves will be able to export pharmaceutical-grade cannabis products to international markets.
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.